Literature DB >> 17380340

[Clinical pathways in rheumatological inpatient treatment - a structured process management].

H-J Lakomek1, J L Hülsemann, T Küttner, K Buscham, N Roeder.   

Abstract

Clinical pathways for three rheumatological indications have been successfully developed in the rheumatological departments of two hospitals. These diseases were selected because of the number of inpatients seen and/or the costs for diagnostics and therapy. Three quota-concepts, the coordination of treatment processes (quota-concept I), the sequence of implementing services (quota-concept II), and the economical utilization of available resources as well as the transparent definition of therapies (quota-concept III) have been established. These concepts have been tested individually as well as in complex situations.

Mesh：

Year:  2007        PMID： 17380340     DOI： 10.1007/s00393-007-0162-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


  6 in total

1.  [The multimodal rheumatologic complex treatment (OPS 8-983)--challenges, solutions and perspectives].

Authors:  H-J Lakomek; W Fiori; K Buscham; J L Hülsemann; N Köneke; W Liman; E Märker-Hermann; N Roeder
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

2.  [What changes for rheumatologists in the G-DRG system 2006?].

Authors:  A Liedtke-Dyong; W Fiori; H-J Lakomek; J L Hülsemann; N Köneke; W Liman; N Roeder
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

3.  [Increasingly appropriate depiction of rheumatology for G-DRG reimbursement 2006].

Authors:  H J Lakomek; W Fiori; K Buscham; J Hülsemann; N Köneke; W Liman; E Märker-Hermann; N Roeder
Journal:  Z Rheumatol       Date:  2006-02       Impact factor: 1.372

4.  [Do we need in-patient rheumatology?].

Authors:  H-J Lakomek
Journal:  Dtsch Med Wochenschr       Date:  2006-10-13       Impact factor: 0.628

5.  [Structural quality of acute internal medicine rheumatology clinics--Project Group of the Association of Rheumatologic Acute Clinics].

Authors:  H J Lakomek; G Neeck; B Lang; J Jung
Journal:  Z Rheumatol       Date:  2002-08       Impact factor: 1.372

6.  [Clinical pathways: effective and efficient inpatient treatment].

Authors:  N Roeder; P Hensen; D Hindle; N Loskamp; H-J Lakomek
Journal:  Chirurg       Date:  2003-12       Impact factor: 0.955
  6 in total
  14 in total

1.  [Hospital financing in 2012 - Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

2.  [The G-DRG System 2009--relevant changes for rheumatology].

Authors:  W Fiori; A Liedtke-Dyong; H-J Lakomek; K Buscham; H Lehmann; W Liman; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2010-05       Impact factor: 1.372

3.  [Changes for the field of rheumatology in the G-DRG-System 2007].

Authors:  A Liedtke-Dyong; W Fiori; H-J Lakomek; A Wenke; W Liman; N Roeder
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372

4.  [G-DRG system 2009: relevant changes for rheumatology].

Authors:  W Fiori; A Liedtke-Dyong; H-J Lakomek; K Buscham; H Lehmann; W Liman; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

5.  [The G-DRG system 2008. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; W Liman; A-K Fuchs; J L Hülsemann; N Roeder
Journal:  Z Rheumatol       Date:  2008-05       Impact factor: 1.372

6.  [Hospital financing for 2011: relevant changes in rheumatology].

Authors:  W Fiori; A Liedtke-Dyong; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2011-04       Impact factor: 1.372

7.  [Hospital financing in 2015. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2015-06       Impact factor: 1.372

8.  [Hospital financing in 2013: relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

9.  [Hospital financing in 2014. Relevant changes for rheumatology].

Authors:  W Fiori; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

Review 10.  [Hospital financing in 2016. Relevant changes for rheumatology].

Authors:  W Fiori; H Bunzemeier; H-J Lakomek; K Buscham; H Lehmann; A-K Fuchs; F Bessler; N Roeder
Journal:  Z Rheumatol       Date:  2016-03       Impact factor: 1.372
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.